Literature DB >> 10644682

Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates.

M Eckhardt1, H Barth, D Blöcker, K Aktories.   

Abstract

Clostridium botulinum C2 toxin is a binary toxin composed of an enzymatic subunit (C2I) capable of ADP-ribosylating actin and a binding subunit (C2II) that is responsible for interaction with receptors on eukaryotic cells. Here we show that binding of C2 toxin depends on the presence of asparagine-linked carbohydrates. A recently identified Chinese hamster ovary cell mutant (Fritz, G., Schroeder, P., and Aktories, K. (1995) Infect. Immun. 63, 2334-2340) was found to be deficient in N-acetylglucosaminyltransferase I. C2 sensitivity of this mutant was restored by transfection of an N-acetylglucosaminyltransferase I cDNA. C2 toxin sensitivity was reduced after inhibition of alpha-mannosidase II. In contrast, Chinese hamster ovary cell mutants deficient in sialylated (Lec2) or galactosylated (Lec8) glycoconjugates showed an increase in toxin sensitivity compared with wild-type cells. Our results show that the GlcNAc residue linked beta-1,2 to the alpha-1,3-mannose of the asparagine-linked core structure is essential for C2II binding to Chinese hamster ovary cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644682     DOI: 10.1074/jbc.275.4.2328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib.

Authors:  J C Marvaud; T Smith; M L Hale; M R Popoff; L A Smith; B G Stiles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding.

Authors:  D Blöcker; H Barth; E Maier; R Benz; J T Barbieri; K Aktories
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells.

Authors:  Masahiro Nagahama; Koichi Nagayasu; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts.

Authors:  Masahiro Nagahama; Akiwo Yamaguchi; Tohko Hagiyama; Noriko Ohkubo; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 5.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

6.  Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.

Authors:  Jörg Fahrer; Joschua Funk; Maren Lillich; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-07       Impact factor: 3.000

7.  Molecular characterization of N-acetylaspartylglutamate synthetase.

Authors:  Ivonne Becker; Julia Lodder; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

8.  Binding and internalization of Clostridium botulinum C2 toxin.

Authors:  Masahiro Nagahama; Tohko Hagiyama; Takashi Kojima; Kouhei Aoyanagi; Chihiro Takahashi; Masataka Oda; Yoshihiko Sakaguchi; Keiji Oguma; Jun Sakurai
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

9.  Clostridium perfringens iota toxin: characterization of the cell-associated iota b complex.

Authors:  Bradley G Stiles; Martha L Hale; Jean Christophe Marvaud; Michel R Popoff
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

10.  N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase.

Authors:  Matthias Eckhardt; Simon N Fewou; Ivonne Ackermann; Volkmar Gieselmann
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.